From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:2ish.gif|left|200px]] | + | {{Seed}} |
| | + | [[Image:2ish.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_2ish| PDB=2ish | SCENE= }} | | {{STRUCTURE_2ish| PDB=2ish | SCENE= }} |
| | | | |
| - | '''Botulinum Neurotoxin A Light Chain WT Crystal Form C'''
| + | ===Botulinum Neurotoxin A Light Chain WT Crystal Form C=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | An efficient research strategy integrating empirically guided, structure-based modeling and chemoinformatics was used to discover potent small molecule inhibitors of the botulinum neurotoxin serotype A light chain. First, a modeled binding mode for inhibitor 2-mercapto-3-phenylpropionyl-RATKML (K(i) = 330 nM) was generated, and required the use of a molecular dynamic conformer of the enzyme displaying the reorientation of surface loops bordering the substrate binding cleft. These flexible loops are conformationally variable in x-ray crystal structures, and the model predicted that they were pivotal for providing complementary binding surfaces and solvent shielding for the pseudo-peptide. The docked conformation of 2-mercapto-3-phenylpropionyl-RATKML was then used to refine our pharmacophore for botulinum serotype A light chain inhibition. Data base search queries derived from the pharmacophore were employed to mine small molecule (non-peptidic) inhibitors from the National Cancer Institute's Open Repository. Four of the inhibitors possess K(i) values ranging from 3.0 to 10.0 microM. Of these, NSC 240898 is a promising lead for therapeutic development, as it readily enters neurons, exhibits no neuronal toxicity, and elicits dose-dependent protection of synaptosomal-associated protein (of 25 kDa) in a primary culture of embryonic chicken neurons. Isothermal titration calorimetry showed that the interaction between NSC 240898 and the botulinum A light chain is largely entropy-driven, and occurs with a 1:1 stoichiometry and a dissociation constant of 4.6 microM.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_17092934}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 17092934 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_17092934}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 25: |
Line 29: |
| | [[Category: Stegmann, C M.]] | | [[Category: Stegmann, C M.]] |
| | [[Category: Botulinum neurotoxin]] | | [[Category: Botulinum neurotoxin]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 07:48:55 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 21:00:37 2008'' |
Revision as of 18:00, 27 July 2008
Template:STRUCTURE 2ish
Botulinum Neurotoxin A Light Chain WT Crystal Form C
Template:ABSTRACT PUBMED 17092934
About this Structure
2ISH is a Single protein structure of sequence from Clostridium botulinum. Full crystallographic information is available from OCA.
Reference
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons., Burnett JC, Ruthel G, Stegmann CM, Panchal RG, Nguyen TL, Hermone AR, Stafford RG, Lane DJ, Kenny TA, McGrath CF, Wipf P, Stahl AM, Schmidt JJ, Gussio R, Brunger AT, Bavari S, J Biol Chem. 2007 Feb 16;282(7):5004-14. Epub 2006 Nov 8. PMID:17092934
Page seeded by OCA on Sun Jul 27 21:00:37 2008
